Results from Phase 2 clinical studies, CHAPTER-1 and RAPIDe-1, provide evidence of viability of bradykinin B2 receptor antagonism in management of HAE ZUG, Switzerland, March 20, 2026 (GLOBE NEWSWIRE) ...
Leading allergy medical societies and patient advocacy groups highlight path forward to advance food allergy prevention, treatment, and managementWashington, DC, March 19, 2026 (GLOBE NEWSWIRE) -- The ...
ALK presents new findings that directly compare user preference between needle-free nasal and injectable adrenaline treatments for anaphylaxis, demonstrating that 88% of participants prefer EURneffy-t ...
Dupilumab yields larger improvements in lung function than several other biologics in patients with severe asthma.
Glaxo Smith Kline’s decision to discontinue a popular children’s asthma inhaler, Flovent, more than two years ago has caused ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results